Get In Touch

The presence of a seamless industry for prenatal care has given a thrust to the growth of the global prenatal and new-born genetic testing market. The rising incidence of prenatal complications has compelled medical practitioners to resort to prenatal testing procedures. Furthermore, advancements in sonography and other related technologies has also helped in creating a seamless fabric for medical testing across the globe. In this scenario, it is safe to expect that the global prenatal and new-born genetic testing market would grow at a boisterous pace in the times to follow. State approval of prenatal testing across several regional territories has created new opportunities for market growth.

  • Genetic testing has emerged as an important means to educate and inform expecting mothers about the possibility of genetic disorders in the baby. Furthermore, genetic testing is also useful for parents who exhibit a history of genetic disorders in their families.
  • The medical fraternity has become more liberal in its approach toward diagnosis and treatment. Prenatal testing is a part of the radical changes that have ensued across the medical industry. The total volume of revenues within the global prenatal and new-born genetic testing market is set to rise in the years to follow.
  • Use of new-born genetic testing for diagnosing the presence of down syndrome in infants is an important function in the medical industry. Medical experts are focusing on developing comprehensive training and education programs for parents of kids with genetic disorders. This move by the medical industry has led to increased use of prenatal and new-born genetic testing.
  • The rising incidence of dyslexia and down syndrome has given a thrust to market growth. The medical industry in Europe has acquired a remarkable level of maturity, and this factor shall play a crucial role in driving sales across the global prenatal and new-born genetic testing market.

Global Prenatal and New-born Genetic Testing Market: Snapshot

Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down syndrome, and Edward syndrome is increasing at a significant pace across the world.

The vast rise in prevalence of genetic abnormalities and late pregnancies are some of the key factors to have led to an increased demand for prenatal and new-born genetic tests across the globe. The vast advancements observed in diagnostic and screening technologies and the rise in awareness about genetic diseases are also considered crucial to the rising demand for genetic tests in children, both before and after birth. Transparency Market Research states that the market will exhibit a remarkable 26.9% CAGR over the report’s forecast period.

Diagnostic Techniques to Continue to Remain Preferred Option for Detecting Chromosomal Abnormalities

The prenatal and newborn genetic testing market can be broadly segmented into screening techniques and diagnostics techniques. Of these, the segment of diagnostic techniques, covering popular genetic testing methods such as fluorescence in-situ hybridization (FISH), array comparative genomic hybridization (aCGH), and polymerase chain reaction (PCR), accounts for a massive share of the market.

Diagnostic techniques are expected to retain their position as the leading contributor of revenue to the global prenatal and newborn genetic testing market over the forecast period, owing to their more effective and accurate results as compared to screening techniques. Of the key genetic diagnostic techniques available in the market, PCR techniques are expected to be the most preferred owing to their high efficiency and varied applications.

Of the key prenatal and newborn genetic screening techniques commonly used across the globe, including maternal serum screening (MSS) and non-invasive prenatal testing (NIPT), the segment of non-invasive prenatal testing is expected to lead the market for prenatal and newborn genetic screening techniques. This is owing to the fact that non-invasive screening techniques completely eliminate the risk of miscarriage associated with invasive tests such as Chorionic Villus Sampling (CVS) and amniocentesis.

Emerging Markets to Present Most Lucrative Growth Opportunities

Presently, North America is the dominant market for the global prenatal and newborn genetic testing market, accounting for a massive chunk of the overall market. Apart from a large pool of highly-aware parents and a rising prevalence of genetic disorders in the region, the large number of companies operating in the diagnostics as well as screening sectors have also helped the prenatal and newborn genetic testing market strengthen its foothold in the region. Another developed region, Europe, is also a mature market for prenatal and newborn genetic testing.

However, in the next few years, the prenatal and newborn genetic testing market will witness the most traction across emerging regional markets such as Asia Pacific, and Middle East and Africa. The vast untapped opportunities in these regions and an encouraging rise in awareness about genetic testing, rising affordability, and increasing prevalence of genetic diseases will together contribute towards the healthy growth of the prenatal and newborn genetic testing market in these regions in the near future.

Some of the key vendors operating in the diagnostics field of prenatal and newborn genetic testing are Ariosa Diagnostics, Bio-Rad Laboratories, Perkin Elmer, and Agilent Technologies. Key vendors operating in the screening segment of prenatal and newborn genetic testing are Verinata Health and Sequenom, Inc.

Genetic testing is a systematic diagnostic and screening technique usually applied to detect risk of genetic disorders in unicellular and multicellular organisms. Genetic testing is broadly segmented as newborn screening, diagnostic testing, carrier testing, prenatal testing, pre-implantation testing, predictive and forensic testing. Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome.

This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic techniques are further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test) and maternal serum screening (MSS). The market for prenatal testing and diagnosis has been analyzed on the basis of the product preferences, usage pattern, applications, equipment cost and distribution of devices. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The prenatal testing and diagnosis report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the prenatal and newborn genetic testing market report offers a qualitative analysis of the overall market considering the factors determining market dynamics such as drivers, restraints and opportunities. To understand the current and future market scenario of the electrophoresis equipment and supplies market Porter’s five force analysis and market attractiveness analysis covers the various aspects related to market environment. The executive summary section of prenatal and newborn genetic testing market comprises of market snapshot covering information about the largest diagnostic technique segment market, diagnostic technique segment with highest CAGR, largest screening methods market, screening methods market with highest CAGR and key player’s market share.

The prenatal and newborn genetic testing market report also provides a highlight of the competitive landscape of the market, wherein the market share analysis of the important players in the market, along with the services offered by them has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the prenatal and newborn genetic testing market and accentuate market shares. The prenatal and newborn genetic testing market report concludes with the profiles of major players having presence in the market such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and Illumina, Inc.

The global prenatal and newborn genetic testing market is segmented as follows:

Prenatal and Newborn Genetic Testing Market, by Technology

  • Diagnostic Techniques

    • Polymerase Chain Reaction (PCR)

    • Fluorescence In-Situ Hybridization &(FISH)

    • Array-Comparative Genomic Hybridization (aCGH)

  • Screening Methods

    • Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)

    • Maternal Serum Screening (MSS)

Prenatal and Newborn Genetic Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW) 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019)
2.2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)
 
Chapter 3 Prenatal and Newborn Genetic Testing Market Overview
3.1 Introduction and Market Definition
3.2 Future Market Outlook
3.3 Regulatory and Reimbursement Scenario for Prenatal and Newborn Screening
3.4 Market Dynamics
      3.4.1 Drivers
      3.4.2 Restraints
      3.4.3 Market Opportunities
3.5 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
 
Chapter 4 Prenatal and Newborn Genetic Testing Market, by Technology
4.1 Overview
      4.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 – 2019 (USD Million)
4.2 Diagnostic Techniques
      4.2.1 Global Diagnostic Techniques Market Revenue, by Types, 2012 – 2019 (USD Million)
      4.2.2 Polymerase Chain Reaction (PCR)
      4.2.3 Fluorescence In-Situ Hybridization  (FISH)
      4.2.4 Array-Comparative Genomic Hybridization (aCGH)
4.3 Screening Methods
      4.3.1 Global Screening Methods Market Revenue, by Types, 2012 – 2019 (USD Million)
      4.3.2 Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)
      4.3.3 Maternal Serum Screening (MSS)
 
Chapter 5 Prenatal and Newborn Genetic Testing Market, by Geography
5.1 Overview
      5.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography2012 – 2019 (USD Million)
5.2 North America
      5.2.1 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
      5.2.2 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
      5.2.3 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
5.3 Europe
      5.3.1 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
      5.3.2 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
      5.3.3 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
5.4 Asia - Pacific
      5.4.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
      5.4.2 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
      5.4.3 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
5.5 Rest of the World (RoW)
      5.5.1 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
      5.5.2 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
      5.5.3 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
 
Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players, 2012 (%)
 
Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Focus on forming alliances with diagnostic service providers in Asia-Pacific countries
      7.1.2 Emphasis on improving technology in order to increase accuracy, reduce the duration of result generation and price
7.2 Barriers and Future Assumptions
      7.2.1 Lack of awareness about prenatal and newborn genetic testing in some Asian countries
      7.2.2 Regulatory compliance and ethical issues
 
Chapter 8 Company Profiles
8.1 Agilent Technologies, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Ariosa Diagnostics, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Bio-Rad Laboratories, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Illumina, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Performance
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Laboratory Corporation of America Holdings (LabCorp)
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Natera, Inc.
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 PerkinElmer, Inc.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Sequenom, Inc.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019)
TABLE 2 Technological Approach for Non-Invasive Prenatal Screening Tests
TABLE 3 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 – 2019 (USD Million)
TABLE 4 Global Diagnostic Techniques Market Revenue, by Types, 2012 – 2019 (USD Million)
TABLE 5 Global Screening Methods Market Revenue, by Types, 2012 – 2019 (USD Million)
TABLE 6 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography, 2012 – 2019 (USD Million)
TABLE 7 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
TABLE 8 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 9 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 10 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
TABLE 11 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 12 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 13 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
TABLE 14 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 15 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 16 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
TABLE 17 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
TABLE 18 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
List of Figures
 
FIG. 1 Prenatal and Newborn Genetic Testing: Market Segmentation
FIG. 2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)
FIG. 3 Adoption Curve Analysis for Genetic Testing Market
FIG. 4 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market
FIG. 5 Market Attractiveness Analysis: Global Prenatal and Newborn Genetic Testing Market, 2012
FIG. 6 Global PCR Market Revenue, 2012 – 2019 (USD Million)
FIG. 7 FISH Procedural Steps
FIG. 8 Global FISH Market Revenue, 2012 – 2019 (USD Million)
FIG. 9 Global aCGH Market Revenue, 2012 – 2019 (USD Million)
FIG. 10 Global NIPT Market Revenue, 2012 – 2019 (USD Million)
FIG. 11 Global MSS Market Revenue, 2012 – 2019 (USD Million)
FIG. 12 Global Prenatal and Newborn Genetic Testing: Market Share, by Key Players, 2012 (%)
FIG. 13 Annual Sales: Agilent Technologies, Inc., 2010 – 2012 (USD Million)
FIG. 14 Annual Sales: Bio-Rad Laboratories, Inc., Clinical Diagnostics Segment, 2010 – 2012 (USD Million)
FIG. 15 Annual Sales: Illumina, Inc., 2010 – 2012 (USD million)
FIG. 16 Annual Sales: LabCorp, 2010– 2012 (USD Million)
FIG. 17 Annual Sales: PerkinElmer, Inc. (Human Health Segment), 2010 – 2012 (USD Million)
FIG. 18 Annual Sales: Sequenom Inc., 2010–2012 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Prenatal New Born Genetic Testing